Indoco Remedies Ltd. — M&A Activity 2026

May 18, 2026

INDOCO

May 18, 2026

| To
The Listing Department
National Stock Exchange of India Limited
Exchange Plaza,
Bandra – Kurla Complex
Bandra (East)
Mumbai – 400 051
Stock Code : INDOCO | To
The Listing Department
Bombay Stock Exchange Limited
Floor 25, P. J. Towers,
Dalal Street,
Mumbai – 400 001
Stock Code : 532612 |
| --- | --- |

Dear Sir/Madam,

Subject: Intimation regarding completion of business transfer to Sunways (India) Private Limited.

This is in continuation to our earlier disclosures dated April 30, 2026, regarding the approval and execution of the Agreement to Transfer Business (“ATB”) for the sale and transfer of the Company’s ophthalmic business (“Ophthalmic Division”) in the territories of India, Benin, Burkina Faso, Ivory Coast, Mali, Niger, Mauritania, Senegal, Cameroon, Congo, Gabon, Kenya, Botswana, Tanzania, Zambia, Zimbabwe, Namibia (“Territories”) as a going concern on a slump sale basis on such terms and conditions as detailed in the ATB.

We wish to inform you that, in line with the approved ATB and all conditions precedent being fulfilled, the Company has completed the transfer of its Ophthalmic Division in the Territories to Sunways (India) Private Limited, as a going concern on a slump sale basis on May 18, 2026.

The above intimation is given to you for your record, kindly take note of the same.

Thanking you,
Yours faithfully,
For Indoco Remedies Limited

RAMANATH AN HARIHARAN
Digitally signed by RAMANATHAN HARIHARAN
Date: 2026.05.18 19:53:26 +05'30'

Ramanathan Hariharan
Company Secretary & Head Legal

INDOCO REMEDIES LIMITED
Indoco House, 166, C.S.T. Road, Kalina, Santacruz (E), Mumbai 400098, India.
Tel. No.: +91 22 6287 1000 / 6879 1250 ■ CIN: L85190MH1947PLC005913
www.indoco.com